Research Article |
Corresponding author: Ali H. Abbas ( alih.phchm@tu.edu.iq ) Academic editor: Emilio Mateev
© 2024 Ali H. Abbas.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Abbas AH (2024) Synthesis and in vitro evaluation of new oxadiazole thioethers as antibacterials. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e139122
|
A study was conducted to synthesize a new set of compounds named comp.4–7 using the 1,3,4 tautomer of oxadiazole as the centroid unit. These compounds were subjected to various characterization processes, including thin-layer chromatography, infrared spectroscopy, and 1HNMR spectroscopy. The study was based on previous research that established several compounds’ diverse range of biological activities, such as hydrazide Schiff’s bases (hydrazones), oxadiazoles, thiophenes, and isoxazoles. These compounds had been found to possess properties against bacteria, fungi, TB, viruses, cancer cells, and inflammatory responses, as well as analgesic properties. The results of the docking study were conducted in MOE software, targeting the largest binding site of E. coli gyrase B (PDB: 6YD9) as identified by SITE FINDER, suggesting that these compounds had great potential to be effective antibacterial agents. To evaluate the synthesized compounds antibacterial activities, the well diffusion method was used, and the findings revealed that the synthesized compounds exhibit slight to moderate activities against E. coli, S. aureus, and K. pneumoniae.
oxadiazoles, Schiff’s base, thiophenes, isoxazoles, antibacterial
Heterocyclic compounds play a vital role in pharmaceutical and material sciences, and oxadiazole is one of the most widely used compounds due to its diverse properties. Among the structural isomers of oxadiazole, 1,3,4-oxadiazole is of particular interest in medicinal chemistry as a promising pharmacophore for developing new drugs with a wide range of activities (
Isoxazole is another five-membered heterocycle having two heteroatoms, which are oxygen and nitrogen, at the adjacent positions. Isoxazole compounds possess many biological activities that are explained by a wide spectrum of protein targets that isoxazole compounds are possible to interact with, such as anticancer, antibacterial, antifungal, antiviral, and anti-inflammatory (
Thiophenes and their derivatives are an important class of heterocyclic compounds that possess a wide spectrum of biological properties, such as antibacterial and antifungal, anti-inflammatory, antioxidant, and antitumor (
In medicinal chemistry, new compounds with improved biological activity can be created by hybridization, which involves combining two or more distinct molecules. Hydrazones [Hydrazide Schiff’s base derivatives] can be considered scaffolds because they possess great potential for various pharmaceutical applications because of their high reactivity and excellent affinity toward numerous biological targets, so they are an attractive option for developing new drugs. A reactive (-CO-NH-N=CH-) group, commonly referred to as an azomethine group, is the unique structure included in these compounds. Because of their unique structure and favorable pharmacological properties, hydrazones have been extensively researched in medicinal chemistry, and a wide range of biological activities, including antibacterial, antifungal, antiviral, and anticancer properties, have been associated with them. In searching for a promising strategy for developing new drugs with enhanced pharmacological properties, hydrazide Schiff’s base derivatives represent attractive ones (
The purity of the synthesized compounds was checked by thin-layer chromatography (TLC), which was conducted using pre-coated aluminum sheets. To facilitate visualization, the aluminum sheets were exposed to a UV light adjusted to 254 nm wavelength. Based on their distinct polarity and ability to separate and distinguish the synthesized compounds, two solvent systems (eluents) named E1 and E2, which were composed of toluene:ethylacetate:ethanol (3:2:1) and ethylacetate:methanol:ammonia (5:3.5:1.5) as parts, respectively, were utilized during the synthesis process. Furthermore, all the synthesized derivatives were characterized through spectroscopic analysis (IR and 1HNMR). (
The following sections involved the details of the synthesis from starting material to final products:
A precise amount of vanillic acid weighing (7.0 g, 42 mmoles) was mixed with methanol, and the resulting solution was cooled to 0 °C. Concentrated H2SO4 (5 mL) was then slowly added drop by drop to the solution, which was stirred at room temperature [before being refluxed for 7 hrs] for 48 hours. TLC results indicate the formation of a product. A precipitate formed with time when the solution was transferred into a crushed ice contained in a suitable beaker, and after the compete precipitation, NaHCO3 (10%) was added wisely until pH was slightly alkaline to get rid of any excess acid and to neutralize the H2SO4. The product was collected by filtration and dried. The desired product was obtained as a yield of 7.0 g through this process (
Comp. 1: whitish-brown powder, yield 91%, M.P: 60–62 °C.
ATR-FTIR spectrum in cm-1: (1686) C=O stretching vibration, (1276) C-(C=O)-O stretching vibration of aromatic ester.
1HNMR (500 MHz, DMSO-d6) in ppm.: 9.99(1H, br s, Ar-OH), 7.46–7.42(2H, m, aromatic protons at positions 2 and 6), 6.88–6.84(1H, d, aromatic proton at position 5), 3.80(3H, s, COOCH3), and 3.83(3H, s, OCH3).
Comp.1 was dissolved in hot absolute ethanol (99.9%) using 5 mL. The amount of Comp.1 (27 mmoles), which is equivalent to (5.0 g). Then, 80% hydrazine hydrate (270 mmoles, 13.5 g) was added to the solution gradually. The reaction was monitored by TLC to track the progress of the reaction, and the results of TLC indicate that 4 hrs as reflux time was required. The reaction system was left to cool to r.t with overnight stirring and cooling, and a white precipitate formed as a solid mass, which was washed with cold ethanol, filtered out, and dried. The product yield was found to be 3.5 g after completion of the drying process (
Comp. 2: white powder, yield 70%, M.P: 208–210 °C.
ATR-FTIR spectrum in cm-1: (3310) phenolic OH stretching vibration overlapped with NH2 asymmetric stretching vibration, (3256) NH amide stretching vibration, (3210) NH2 symmetric stretching vibration, (1628) C=O stretching vibration of amide, (1600) NH bending vibration, and (1585) NH bending vibration of amide.
1HNMR (400MHz, DMSO-d6) in ppm: 9.52(2H, s, CONH and Ar-OH), 7.4–7.29(2H, m, aromatic protons at positions 2 and 6), 6.84–6.76(1H, d, aromatic proton at position 5), 4.38(2H, s, NH-NH2), and 3.78(3H, s, OCH3).
A compound mixture was prepared by suspending comp.2 (6.86 mmoles, 1.25 g) in 30 mL of 50% ethanol. CS2 (0.0103 mmoles, 0.785 g) was then added to the mixture and stirred for a few minutes. Next, KOH (10.3 mmoles, 0.7 g) was introduced, and the whole mixture was refluxed for 12 hours. The progress of the reaction was monitored by TLC, and the evolution of H2S was noted for better observation. Upon completion of the refluxing process, conc. HCl was added dropwise to a beaker containing the reaction solution and 30 mL of crashed ice. Precipitate began to be formed and increased until the pH of the mixture became 2–3 [no further precipitate was formed]. The precipitate was then filtered, dried, and purified using the base to dissolve the product and then acidification to reform the pure product, which was 0.9 g (
Comp. 3: faint yellow powder, yield 59%, M.P: 186–189 °C.
ATR-FTIR spectrum in cm-1: (3452) phenolic OH stretching vibration, (3155) NH (br stretching), 2670(w) SH stretching vibration.
1 HNMR (400 MHz, DMSO-d6) in ppm.: 14.58(1H, s, -SH), 10.04(1H, s, Ar-OH), 7.37–7.3(2H, m, aromatic protons at positions 2 and 6), 6.94–6.92(1H, d, aromatic proton at position 5), and 3.84(3H, s, OCH3).
A chemical compound known as comp.3, weighing (2.23 mmoles, 0.5 g) was dissolved completely in 5 mL of absolute ethanol. To the solution, triethylamine (0.00223 mmoles or 0.22564 g) was added gradually, and after a few minutes of gentle and constant stirring, [4-(chloromethyl) benzaldehyde (0.00223 mmoles or 0.345 g)] was added to the mixture. The solution was heated gently to a temperature of about 50 °C, which resulted in the formation of a precipitate. The precipitate was then filtered, dried, and finally crystallized from a mixture of boiled absolute ethanol and 2-methoxy ethanol (
Comp. 4: white crystals, yield 65.5%, M.P: 167–169 °C.
ATR-FTIR spectrum in cm-1: (3417–2830) broad phenolic OH stretching vibration, (2735) CH stretching vibration of aldehyde, and (1697) C=O stretching vibration of aldehyde carbonyl.
1 HNMR (400MHz, DMSO-d6) in ppm: 9.98(1H, s, Ar-OH), 9.97(1H, s, COH), 7.9–7.88(2H, d, aromatic protons at positions 10 and 12), 7.71–7.69(2H, d, aromatic protons at positions 9 and 13), 7.41–7.38(2H, m, aromatic protons at positions 2 and 6), 6.95–6.93(1H, d, aromatic proton at position 5), 4.65(2H, s, -S-CH2), and 3.85(3H, s, OCH3).
Comp.4 (0.3 mmole, 0.1 g) was suspended in 5 mL of absolute ethanol. Three drops of glacial acetic acid were added to the suspension with constant stirring for 15 minutes. Then, 4-hydroxybenzohydrazide (0.3 mmole, 0.044 g) was added to the mixture, and the reaction mixture was refluxed for 30 minutes. During this process, the suspension became a clear solution. The reaction mixture was then allowed to stir gently overnight. The formed precipitate was filtered and dried. The excess solvent was evaporated, and the product was crystallized from hot absolute ethanol. The final yield of pure product was 0.09 g (
Comp. 5: white powder, yield 65%, M.P: 230–232 °C.
ATR-FTIR spectrum in cm-1: (3418) stretching vibration of two phenolic OH, (3244) NH amide stretching vibration, (1647) C=O stretching vibration of amide carbonyl, and (1608) C=N stretching vibration of imine.
1 HNMR (400MHz, DMSO-d6) in ppm: 11.64(1H, s, CONH), 10.12(1H, s, Ar-OH`), 9.96(1H, s, Ar-OH), 8.41(1H, s, -N=CH-), [7.81–7.79, 7.7–7.68, 7.56–7.54] (6H, d, aromatic protons at positions 9, 10, 12, 13, 17, and 21), 7.43–7.39(2H, m, aromatic protons at positions 2, and 6), 6.96–6.94(1H, d, aromatic proton at position 5), 6.87–6.85(2H, d, aromatic protons at positions 18, and 20), 4.6(2H, s, -SCH2-), and 3.86(3H, s, OCH3).
Comp.3, which had a weight of (0.67 mmole, 0.15 g), was dissolved in 3 mL of absolute ethanol. After that, (0.67 mmole, 0.0677 g) of triethylamine was added to the mixture and stirred for 10–15 minutes. Subsequently, (0.67 mmole, 0.1118 g) of 2-chloro-5-(chloromethyl)thiophene was added, and the reaction mixture was refluxed for 2 hours. Once the refluxing was complete, D.W. was added until a precipitate appeared, and the mixture was then filtered, dried, and subjected to crystallization using a two-solvent system of hot absolute ethanol and hot D.W (1:1) (
Comp. 6: white crystals, yield 48%, M.P: 139–141 °C.
ATR-FTIR spectrum in cm-1: (2978 and 2893) asymmetric and symmetric stretching vibration of CH2, (1447) bending vibration of CH2.
1HNMR(400MHz, DMSO-d6) in ppm: 9.96(1H, s, Ar-OH), 7.44–7.42(2H, m, aromatic protons at positions 2 and 6), 7.01–6.93(3H, m, protons of thiophene ring and aromatic protons at positions 5, 9, and 10), 4.75 (2H, s, -SCH2-), 3.86(3H, s, OCH3).
Comp. 7 was prepared by the same procedure that was followed in the preparation of comp. 6, except crystallization was from hot absolute ethanol only (
Comp. 7: white crystals, yield 47%, M.P: 116–118 °C.
ATR-FTIR spectrum in cm-1: (2982 and 2835) asymmetric and symmetric stretching vibration of CH2, (1632) stretching vibration of (–O-C=N-), (1466) asymmetric bending vibration of CH3 and scissoring bending vibration of CH2, (1369) symmetrical bending vibration of CH3 groups.
1HNMR (400MHz, DMSO-d6) signals in ppm: 9.96 (1H, s, Ar-OH), 7.43–7.4 (2H, m, aromatic protons at positions 2 and 6), 6.97–6.93 (1H, d, aromatic proton at position 5), 4.39 (2H, s, -SCH2-), 3.85 (3H, s, OCH3), 2.35 (3H, s, methyl protons at position near to O), 2.24 (3H, s, methyl protons at position near to N).
Molecular docking investigations were conducted on the E. coli DNA-binding protein 6YD9 (DNA Gyrase), leveraging its high-resolution (1.60 Å) crystal structure derived from X-ray crystallography. The protein is composed of a single chain (chain A) harboring a co-crystal ligand (ON2) binding site. Docking was executed on chain A following preparatory measures encompassing water removal, binding site delineation, and hydrogen addition. The AMBER10 force field was employed for energy minimization purposes. The MOE 2022 software facilitated molecular docking, with the SMILE representations of the investigated compounds generated via ChemBioDraw Ultra 13.0. These were subsequently transformed into 3D configurations within MOE 2022, followed by protonation and energy minimization utilizing the AMBER 10 force field with a 0.1 Å RMSD. Validation of the docking procedure involved re-docking the co-crystallized ligand (NO2). An RMSD value of 1.18 Å, computed using Discovery Studio Visualizer and VMD, substantiated the precision of the MOE program for docking the novel ligands (Prieto-Martinez et al. 2019;
To examine inhibition bacterial growth related to the synthesized compounds, diffusion assays were performed. In which McFarland turbidity of 0.5, having a concentration of around 1.5×108 colony-forming units per milliliter, was the standard to compare with the prepared bacterial suspension. The inoculated mixture was applied to the surface Mueller-Hinton agar plates. After inoculation, a current of sterile air under a hood was applied to remove any excess liquid. To assess the efficacy of the synthesized compounds in combating bacterial growth, in each agar plate of the examined bacteria, four wells were created. Then, 80 μl of each concentration of the compounds, at 1000 μg/mL, were poured into these wells. These plates were placed in an incubator set at 37 °C for 24 hours. Following the incubation period, the diameter of the inhibition zone formed around each well was measured to determine the potency of the targeted compounds (
A successful multi-step reaction process was executed, which involved the synthesis of several new compounds, as shown in Fig.
Next, Comp. 1 was refluxed in absolute ethanol with hydrazine hydrate 80% to produce Comp. 2 (
Furthermore, Comp. 3 was obtained by refluxing the ethanolic suspension of Comp. 2 with CS2 in the presence of KOH (
Comp. 4, Comp. 6, and Comp. 7 were obtained through a reaction between Comp. 3 as nucleophilic species and 4-(chloromethyl) benzaldehyde (Comp. 4), 2-chloro-5-(chloromethyl)thiophene (Comp. 6), or 4-(chloromethyl)-3,5-dimethyl isoxazole (Comp. 7) as electrophiles in the presence of a base catalyst and absolute ethanol as reaction solvent (
1 HNMR is characterized by the presence of a new proton at 9.97 ppm of COH as a singlet, four aromatic protons from 7.9–7.69 ppm related to the benzene ring of 4-(chloromethyl) benzaldehyde, and the absence of a SH proton at 14.58 ppm and instead the appearance of new two protons as a singlet at 4.65 ppm for comp. 4, 4.75 ppm for comp. 6, and 4.35 ppm for comp. 7, which related to –SCH2. The appearance of new protons in the aromatic region due to the thiophene ring in comp.6, and finally the appearance of six protons at their expected sites due to two methyl groups of 3,5-dimethylisoxazole in comp. 7.
Lastly, Comp. 5 is a Schiff base product of hydrazone type obtained by reacting aldehydes with primary amines in mildly acidic conditions (
Molecular docking simulations were conducted in MOE software, targeting the largest binding site of E. coli gyrase B (PDB: 6YD9) as identified by SITE FINDER. An induced-fit docking protocol, incorporating ligand and protein flexibility, was employed. Each molecule was allowed a maximum of five interactions with the protein (Figs
Scores for docking of tested compounds against the target site of co-crystallized ligand are represented in ∆G values measured in kcal/mol.
Ligand | RMSD value | Docking score (Kcal/mol) |
---|---|---|
Cocrystal (ON2) | 1.18 | -6.28 |
Comp. 4 | 1.68 | -7.26 |
Comp. 5 | 2.01 | -8.06 |
Comp. 6 | 1.58 | -7.43 |
Comp. 7 | 1.75 | -7.95 |
There are different levels of activity that can be measured using a unit called ZI. When there is no activity, ZI is equal to zero. When activity is present, ZI can range from 5 to 10 mm for slightly active, 10 to 15 mm for moderately active, and more than 15 mm for highly active (
At a concentration of 1000 μg/mL, four of the compounds (comp. 4, 5, 6, and 7) showed excellent antibacterial activity against E. coli, which was comparable to that of amoxicillin. Another compound (comp. 5) demonstrated slightly better antibacterial activity than amoxicillin when tested against S. aureus, but its activity was lower than that of cefixime at a concentration of 1000 μg/mL.
Furthermore, comp. 6 showed similar activity to amoxicillin when tested against S. aureus, and it exhibited comparable activity to both amoxicillin and cefixime when tested against K. pneumoniae. Interestingly, comp. 5 demonstrated the best activity among all derivatives tested against S. aureus, while showing the least activity against E. coli. This can be attributed to the compound’s hydrophobicity, as more hydrophobic compounds tend to be more effective against gram-positive bacteria (
It is worth noting that none of the compounds synthesized in the study showed any significant activity against S. pyogenes, B. subtilis or P. aeruginosa (Table
Comp. name | Conc. μg/mL | Gram (+)ve | Gram (-)ve | ||||
---|---|---|---|---|---|---|---|
S. pyogenes | S. aureus | B. subtilis | P. aeruginosa | E. coli | K. pneumoniae | ||
Zone of inhibition (mm) | |||||||
Comp. 4 | 103 | - | 8 | - | - | 11 | - |
Comp. 5 | 103 | - | 14 | - | - | 10 | - |
Comp. 6 | 103 | - | 13 | - | - | 12 | 11 |
Comp. 7 | 103 | - | 6 | - | - | 11 | - |
Amoxicillin | 103 | 5 | 13 | 40 | 28 | 11 | 11.5 |
Cefixime | 103 | 6 | 16 | 20 | 6 | 22 | 13 |
Nitrofurantoin | 103 | 9.5 | 21 | 31 | 17 | 16 | 20 |
DMSO | Solvent and control | - | - | - | - | - | - |
Understanding the physicochemical characteristics of drugs is crucial to making them work better. One important factor is the partition coefficient (logP), which can be computed in silico (clogP). It gives an idea about how drugs move around inside the human body. Interestingly, all the synthesized compounds under consideration have a clogP value less than 5, which goes in accordance with a common rule called the Lipinski rule of five. Another important thing to consider is the total polar surface area (TPSA). This gives information about the surface area taken up by parts of the drug that are attracted to water. Drugs with lower TPSA values are usually better because they can pass through cell membranes more easily. So, by carefully studying these factors, it is possible to improve how well drugs work and help patients get better results from their treatments (Table
The properties related to physical and chemical characteristics of the compounds that were synthesized.
Comp. | ClogP | Ali class | n. H-bond acceptors | n. H-bond donors | n. rotatable bonds | TPSA / °A |
---|---|---|---|---|---|---|
Comp. 4 | 2.92 | Moderately soluble | 6 | 1 | 6 | 110.75 |
Comp. 5 | 3.50 | Poorly soluble | 9 | 3 | 9 | 155.37 |
Comp. 6 | 3.82 | Poorly soluble | 5 | 1 | 5 | 121.92 |
Comp. 7 | 2.76 | Moderately soluble | 7 | 1 | 5 | 119.71 |
A rigorous in silico investigation of the ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiles of the newly synthesized compounds was conducted employing the SwissADME cheminformatics software and ADMETlab 3.0 web server. This comprehensive analysis facilitated the identification of promising drug candidates exhibiting favorable safety profiles and the exclusion of compounds demonstrating undesirable ADMET characteristics from further progression into subsequent drug development stages. A detailed tabulation of the predicted ADMET properties for the target compounds is presented in Tables
Analysis of ADMET properties has been predicted for the mentioned compounds.
Comp. | CYP2C9 | CYP2D6 | CYP3A4 | BBB | GI absorption | P-gp substrate | |||
---|---|---|---|---|---|---|---|---|---|
S | I | S | I | S | I | ||||
Comp. 4 | P | Yes | No | No | No | Yes | No | High | No |
Comp. 5 | No | Yes | No | No | P | Yes | No | Low | No |
Comp. 6 | P | Yes | P | No | P | Yes | No | High | No |
Comp. 7 | No | Yes | No | No | P | Yes | No | High | Yes |
Comp. | Hepatotoxicity* | Nephrotoxicity* | Ototoxicity* | Genotoxicity* | Neurotoxicity* | Hematotoxicity* |
---|---|---|---|---|---|---|
Comp. 4 | 0.646 | 0.271 | 0.292 | 0.819 | 0.34 | 0.126 |
Comp. 5 | 0.693 | 0.321 | 0.329 | 0.999 | 0.35 | 0.045 |
Comp. 6 | 0.735 | 0.542 | 0.435 | 0.979 | 0.133 | 0.144 |
Comp. 7 | 0.896 | 0.602 | 0.814 | 0.999 | 0.124 | 0.383 |
Through a conventional synthesis method, a set of new oxadiazole-thioether derivatives was successfully developed and characterized by thin-layer chromatography, infrared spectroscopy, and 1HNMR spectroscopy. The docking studies were conducted in MOE software, targeting the largest binding site of E. coli gyrase B (PDB: 6YD9). In an effort to evaluate their potential as antibacterial agents, these derivatives were tested and found to exhibit activity against E. coli, K. pneumoniae, and S. aureus. Notably, Comp. 6 was found to have a particularly broad spectrum of activity. Future studies could focus on advanced modeling, SAR analysis, and testing against resistant strains to enhance potency and clinical potential. Investigating combination therapies and mechanisms of action may also address antimicrobial resistance. Comp. 6, with its broad spectrum activity, shows promise as a lead for next-generation antibacterial agents.
Conflict of interest
The author has declared that no competing interests exist.
Ethical statements
The author declared that no clinical trials were used in the present study.
The author declared that no experiments on humans or human tissues were performed for the present study.
The author declared that no informed consent was obtained from the humans, donors or donors’ representatives participating in the study.
The author declared that no experiments on animals were performed for the present study.
The author declared that no commercially available immortalised human and animal cell lines were used in the present study.
Funding
No funding was reported.
Author contributions
The author solely contributed to this work.
Author ORCIDs
Ali H. Abbas https://orcid.org/0000-0002-2387-809X
Data availability
All of the data that support the findings of this study are available in the main text or Supplementary Information.
ATR-FTIR
Data type: pdf
1HNMR
Data type: pdf